Recent advances in the treatment of gynecologic cancers are promising, and education is needed to ensure that both oncology and primary care clinicians, including OB/GYNs, have a thorough knowledge of biomarkers, current and emerging therapies, and how the latest clinical trial data translates to real-world practice. In particular, the multidisciplinary healthcare team must develop strategies for treating endometrial cancer amid the expanding options, including utilizing molecular testing and immune checkpoint inhibitors (ICI) in front-line advanced and recurrent endometrial cancer. In the second activity of this CME Outfitters podcast series on gynecologic cancers, expert faculty will present and discuss the very latest research on treatment of endometrial cancer, including strategies that utilize molecular testing and ICI therapies.
- Provider:CME Outfitters, LLC
- Activity Link: https://www.cmeoutfitters.com/activity/expanding-options-for-immune-checkpoint-inhibitors-in-front-line-advanced-recurrent-endometrial-cancer/
- Start Date: 2024-10-31 05:00:00
- End Date: 2024-10-31 05:00:00
- Credit Details: IPCE Credits: 0.5 hours
AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - MOC Credit Details: ABIM - 0.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: AstraZeneca (Any division) - Amount: 0 - Is Kind Support: False Source: Merck (Any division) - Amount: 0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Internal Medicine, Medical Oncology